Karakteristik Pasien Kanker Anak Dengan Demam Neutropenia Di Rsup. Haji Adam Malik Medan Tahun Maret 2011 - Maret 2015

DAFTAR PUSTAKA

Ammann, R., Bodmer, N., Hirt, A., Niggli, F., Nadal, D., Simon, A., Ozsahin, H., Kontny, U., Kuhne,
T., Popovic, M., Luthy, A. and Aebi, C. ,2010. Predicting Adverse Events in Children With
Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter SPOG 2003 FN
Study. Journal of Clinical Oncology, 28(12), pp.2008-2014.
Asturias, E., Quezada, J. and Corral, J., 2010. Evaluation of six risk factors for the development of
bacteremia in children with cancer and febrile neutropenia. Current Oncology, 17(2).
Bhatt, Varsha, and Abdus Saleem. "Druginduced Neutropenia – Pathophysiology, Clinical Features,
And Management". Annals of Clinical & Laboratory Science vol. 34.no. 2 (2004): 131-137.
Web. 21 Sept. 2015.
Boxer, L ., Walkovich, K. , 2013. How to Approach Neutropenia in Childhood. Pediatrics in Review,
34(4), pp.173-184.
Braden,C.D.Emedicine.medscape.com,

2015.

Neutropenia .

Available


at:

http://emedicine.medscape.com/article/204821-overview#aw2aab6b2b4aa [Accessed 19 April
2015].
Brinkmann, V. and Zychlinsky, A. ,2012. Neutrophil extracellular traps: Is immunity the second
function of chromatin?. The Journal of Cell Biology, 198(5), pp.773-783.
Castagnola, E., Garrè, M., Bertoluzzo, L., Pignatelli, S., Pavanello, M., Caviglia, I., Caruso, S.,
Bagnasco, F., Moroni, C., Tacchella, A. and Haupt, R. (2011). Epidemiology of Febrile
Neutropenia in Children With Central Nervous System Tumor. Journal of Pediatric
Hematology/Oncology, 33(7), pp.e310-e315.

Crawford, J., Dale, D. and Lyman, G. ,2004. Crawford J, Dale DC, Lyman GH. Chemotherapyinduced neutropenia: risks, consequences, and new directions for its management.Cancer.
(2004) 100(2):228-37. Cancer , 100(9), pp.1993-1994.
Dalal ,S, , Zhukovsky .,2006 .Pathophysiology and Management of Fever. The Journal Of Supportive
Oncology.
Freifeld, A., Bow, E., Sepkowitz, K., Boeckh, M., Ito, J., Mullen, C., Raad, I., Rolston, K., Young, J.
and Wingard, J. ,2011. Clinical Practice Guideline for the Use of Antimicrobial Agents in
Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America.
Clinical Infectious Diseases, 52(4), pp.e56-e93..


Gonzalez-Ibarra, F., Eivaz-Mohammadi, S., Surapaneni, S., Alsaadi, H., Syed, A., Badin, S., Marian,
V. and Elamir, M. (2014). Methotrexate Induced Pancytopenia. Case Reports in
Rheumatology, 2014, pp.1-4.

Hassan, B. A.Rasool , Mohd Yusoff Z B , Othman .S., 2010.Clinical Signs and Association with
Neutropenia in Solid Cancer Patients - Bacterial Infection as the Main Cause. Asian Pacific

Journal of Cancer Prevention, Vol 11.
Kliegman, Rober M. Nelson Textbook Of Pediatrics, 19th Editon. [ Halaman 746- 751 ]
Lehrnbecher, T., Phillips, R., Alexander, S., Alvaro, F., Carlesse, F., Fisher, B., Hakim, H., Santolaya,
M., Castagnola, E., Davis, B., Dupuis, L., Gibson, F., Groll, A., Gaur, A., Gupta, A., Kebudi,
R., Petrilli, S., Steinbach, W., Villarroel, M., Zaoutis, T. and Sung, L. ,2012. Guideline for the
Management of Fever and Neutropenia in Children With Cancer and/or Undergoing
Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology, 30(35), pp.44274438.
Lyman, G. (2005). Risk Models for Predicting Chemotherapy-Induced Neutropenia. The
Oncologist, 10(6), pp.427-437.
Lyman, G. and Kuderer, N. ,2003. Epidemiology of Febrile Neutropenia. Supportive Cancer
Therapy, 1(1), pp.23-35.

Lyman, G., Abella, E. and Pettengell, R. ,2014. Risk factors for febrile neutropenia among patients

with cancer receiving chemotherapy: A systematic review. Critical Reviews in
Oncology/Hematology, 90(3), pp.190-199..

Marinella . M., 2015. Fever in Patients with Cancer - Infectious Disease and Antimicrobial
Agents.Antimicrobe.org. Available at: http://www.antimicrobe.org/new/e13.asp#t1 [Accessed

26 Mei 2015].
Nader, d. ,2015. Medscape Drugs & Diseases . Emedicine.medscape.com. Available from:
http://emedicine.medscape.com/article/208576overview#aw2aab6b5 [Accessed 5 Mei 2015].
Nwakoby, I., Reddy, K., Patel, P., Shah, N., Sharma, S., Bhaskaran, M., Gibbons, N., Kapasi, A. and
Singhal, P. ,2001. Fas-Mediated Apoptosis of Neutrophils in Sera of Patients with Infection.
Infection and Immunity, 69(5), pp.3343-3349.

Saito, T., Aiba, K. , 2013 . Pathophysiology and diagnosis of cancer patients with febrile neutropenia
. Dept. of Internal Medicine, The Jikei University School of Medicine, Japan.
Schouten, H. ,2006. Neutropenia management. Annals of Oncology, 17(suppl 10), pp.x85-x89.
Segal, A. ,2005. How Neutrophils Kill Microbes. Annual Review of Immunology, 23(1), pp.197-223.
Segel, G. and Halterman, J. ,2008. Neutropenia in Pediatric Practice. Pediatrics in Review, 29(1),
pp.12-24.
Staff, h. ,2015. Body Temperature | University of Michigan Health System. Uofmhealth.org.

Available from : http://www.uofmhealth.org/health-library/hw198785 [Accessed 17 mei
2015].
Territo .M .,2015 Neutropenia (Agranulocytosis; Granulocytopenia ). Merck Sharp & Dohme Corp.,
a subsidary of Merck & Co., Inc., Whitehouse Station, NJ., USA.
WHO, 2010. Assessing National Capacity For The Prevention And Control Of Noncommunicable
Diseases. Available from:

http://www.who.int/cancer/publications/national_capacity_prevention_ncds.pdf [Accessed
:28 Maret 2015]
WHO,

2015.

Noncommunicable

Diseases.

Available

from


:

http://www.who.int/mediacentre/factsheets/fs355/en/.[Accessed :28 Maret 2015]
Yoaifoundation.org, (2015). YOAI | Yayasan Onkologi Anak Indonesia . Available from:
http://www.yoaifoundation.org/lang-en.html [Accessed :29 Maret 2015]